Lucio Leprosy with Lucio's phenomenon, digital gangrene and anticardiolipin antibodies.
暂无分享,去创建一个
C. Massone | A. Clapasson | Enrico Nunzie | L. V. Ortega Cabrera | F. M. Macanchi Moncayo | P. F. Ortega Espinosa
[1] L. P. V. Cardoso,et al. Multibacillary leprosy patients with high and persistent serum antibodies to leprosy IDRI diagnostic-1/LID-1: higher susceptibility to develop type 2 reactions , 2015, Memorias do Instituto Oswaldo Cruz.
[2] I. Estrada-García,et al. Lepromatous leprosy patients produce antibodies that recognise non-bilayer lipid arrangements containing mycolic acids. , 2012, Memorias do Instituto Oswaldo Cruz.
[3] J. S. Velarde-Félix,et al. The leprosy agents Mycobacterium lepromatosis and Mycobacterium leprae in Mexico , 2012, International journal of dermatology.
[4] H. Tan,et al. Identification of the leprosy agent Mycobacterium lepromatosis in Singapore. , 2012, Journal of drugs in dermatology : JDD.
[5] J. Fernández‐Díez,et al. Lucio's Phenomenon Is a Necrotizing Panvasculitis: Mostly a Medium-Sized Granulomatous Arteritis , 2008, The American Journal of dermatopathology.
[6] J. Spencer,et al. A new Mycobacterium species causing diffuse lepromatous leprosy. , 2008, American journal of clinical pathology.
[7] F. Vargas‐Ocampo. Diffuse leprosy of Lucio and Latapí: a histologic study. , 2007, Leprosy review.
[8] L. Azulay-Abulafia,et al. [Lucio phenomenon. Vasculitis or occlusive vasculopathy?]. , 2006, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.
[9] S. Akerkar,et al. Leprosy & gangrene: A rare association; role of anti phospholipid antibodies , 2005, BMC infectious diseases.
[10] R. Asherson,et al. Anticardiolipin, anti-β2-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease , 2003, Annals of the rheumatic diseases.
[11] S. Ng,et al. Fatal Lucio's phenomenon in 2 patients with previously undiagnosed leprosy. , 2003, Journal of the American Academy of Dermatology.
[12] L. Carreras,et al. High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity , 2000, Lupus.
[13] G. Hughes,et al. Antiphospholipid antibodies in leprotic patients: a correlation with disease manifestations. , 2000, Clinical and experimental rheumatology.
[14] E. Nunzi,et al. beta 2-Glycoprotein I-dependence of anticardiolipin antibodies in multibacillary leprosy patients. , 1998, Leprosy review.
[15] E. Housley. Anti phospholipid syndrome. , 1995, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[16] Y. Shoenfeld,et al. Anticardiolipin Antibodies in Infections are Heterogenous in Their Dependency on β 2-Glycoprotein I: Analysis of Anticardiolipin Antibodies in Leprosy , 1994, Lupus.
[17] S. Kaur,et al. Vascular involvement in leprosy. , 1989, Indian journal of leprosy.
[18] Ridley Ds,et al. Classification of leprosy according to immunity. A five-group system. , 1966 .
[19] J. Jessurun,et al. Severe leprosy reactions due to Mycobacterium lepromatosis. , 2013, The American journal of the medical sciences.
[20] M. Magaña. Lucio’s Phenomenon , 2012 .
[21] E. Sato,et al. Anti-β2-glycoprotein I antibodies are highly prevalent in a large number of Brazilian leprosy patients. , 2011, Acta reumatologica portuguesa.
[22] Chan Jun-mi,et al. International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome(APS) , 2008 .
[23] D. N. Cohen. Granulomatous arteritis. , 1975, Comprehensive therapy.
[24] A. Carayon,et al. [A type of nonspecific nerve lesion in lepers]. , 1970, Bulletin de la Societe medicale d'Afrique noire de langue francaise.
[25] D. Ridley,et al. Classification of leprosy according to immunity. A five-group system. , 1966, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.
[26] F. Latapí,et al. The " Spotted " Leprosy of Lueio (La lepra " Manchada " de Lucio). An Introduction to its Clinical and Histological Study. , 1948 .